Eton Pharmaceuticals, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() ABOS
Acumen Pharmaceuticals, Inc. |
$1.85 | $157.41 M | -2.5 | 51 | $0 |
![]() ALDX
Aldeyra Therapeutics, Inc. |
$5.27 | $229.34 M | -7.57 | 9 | $0 |
![]() ALEC
Alector, Inc. |
$2.02 | $420.24 M | -3.14 | 238 | $100.56 M |
![]() BDTX
Black Diamond Therapeutics, Inc. |
$2.13 | $291.95 M | -3.13 | 24 | $0 |
![]() CELC
Celcuity Inc. |
$13.17 | $501.59 M | -5.14 | 55 | $0 |
![]() CNTB
Connect Biopharma Holdings Limited |
$1.16 | $108.00 M | -1.81 | 81 | $0 |
![]() ELDN
Eledon Pharmaceuticals, Inc. |
$4.64 | $107.05 M | -2.26 | 20 | $0 |
![]() ELVN
Enliven Therapeutics, Inc. |
$24.07 | $984.95 M | -11.97 | 57 | $0 |
![]() ELYM
Eliem Therapeutics, Inc. |
$5.11 | $258.33 M | -17.08 | 9 | $0 |
![]() GOSS
Gossamer Bio, Inc. |
$1.09 | $124.06 M | -0.65 | 135 | $0 |
![]() HARP
Harpoon Therapeutics, Inc. |
$23.01 | $865.08 M | -15.04 | 45 | $31.92 M |
![]() INBX
Inhibrx Biosciences, Inc. |
$16.52 | $241.02 M | -1.44 | 166 | $1.80 M |
![]() KRON
Kronos Bio, Inc. |
$0.97 | $44.62 M | -0.37 | 62 | $6.29 M |
![]() LIAN
LianBio |
$0.32 | $34.47 M | -0.39 | 163 | $0 |
![]() LYRA
Lyra Therapeutics, Inc. |
$0.22 | $19.53 M | -0.27 | 88 | $1.56 M |
![]() MACK
Merrimack Pharmaceuticals, Inc. |
$15.15 | $223.75 M | -168.11 | 0 | $0 |
![]() NUVB
Nuvation Bio Inc. |
$2.84 | $684.66 M | -8.66 | 220 | $7.87 M |
![]() NVCT
Nuvectis Pharma, Inc. |
$6.61 | $116.38 M | -4.5 | 13 | $0 |
![]() PASG
Passage Bio, Inc. |
$0.76 | $73.04 M | -0.77 | 58 | $0 |
![]() REPL
Replimune Group, Inc. |
$12.02 | $485.18 M | -2.44 | 331 | $0 |
![]() TARS
Tarsus Pharmaceuticals, Inc. |
$56.20 | $1.22 B | -6.78 | 323 | $182.95 M |
![]() TCRR
TCR2 Therapeutics Inc. |
$1.48 | $58.11 M | -0.35 | 58 | $0 |
![]() TVTX
Travere Therapeutics, Inc. |
$18.71 | $542.80 M | -1.32 | 385 | $233.18 M |